1. SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8
- Author
-
Eva M, Stevenson, Sandra, Terry, Dennis, Copertino, Louise, Leyre, Ali, Danesh, Jared, Weiler, Adam R, Ward, Pragya, Khadka, Evan, McNeil, Kevin, Bernard, Itzayana G, Miller, Grant B, Ellsworth, Carrie D, Johnston, Eli J, Finkelsztein, Paul, Zumbo, Doron, Betel, Friederike, Dündar, Maggie C, Duncan, Hope R, Lapointe, Sarah, Speckmaier, Nadia, Moran-Garcia, Michelle Premazzi, Papa, Samuel, Nicholes, Carissa J, Stover, Rebecca M, Lynch, Marina, Caskey, Christian, Gaebler, Tae-Wook, Chun, Alberto, Bosque, Timothy J, Wilkin, Guinevere Q, Lee, Zabrina L, Brumme, and R Brad, Jones
- Subjects
CD4-Positive T-Lymphocytes ,Vaccines, Synthetic ,COVID-19 Vaccines ,SARS-CoV-2 ,Vaccination ,COVID-19 ,HIV Infections ,CD8-Positive T-Lymphocytes ,Granzymes ,Virus Latency ,HIV-1 ,Humans ,RNA, Messenger ,mRNA Vaccines ,nef Gene Products, Human Immunodeficiency Virus ,BNT162 Vaccine - Abstract
Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by CD8
- Published
- 2022